Cynvenio Launches Early Access Program for Liquid Biopsy Platform | GenomeWeb

NEW YORK (GenomeWeb) – Cynvenio Biosystems today announced the launch of an early access program for its LiquidBiopsy Rare Cell Isolation Platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.